NFKB1 and myocardial infarction: Strikingly, enhanced NF-κB activity increased mitochondrial ROS production in the left ventricle of obese mice [53] and both, genetic or pharmacological NF-κB inhibition, ameliorated reperfusion injury following MI through the inhibition of inflammation, ROS, and apoptotic and necrotic pathways [54–57].